Home/Filings/4/0001104659-18-022141
4//SEC Filing

Harshbarger Benjamin 4

Accession 0001104659-18-022141

CIK 0000827809other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:01 PM ET

Size

5.5 KB

Accession

0001104659-18-022141

Insider Transaction Report

Form 4
Period: 2018-04-01
Harshbarger Benjamin
General Counsel and Secretary
Transactions
  • Tax Payment

    Common Stock

    2018-04-01$3.50/sh52$1824,465 total
Footnotes (2)
  • [F1]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of 177 restricted stock units on April 1, 2018.
  • [F2]This total includes 2,667 unvested restricted stock units which were reported in Table II at the time the restricted stock unit awards were granted, as well as the shares settled after the tax withholding and vesting event described in footnote number 1. Each restricted stock unit represents a contingent right to receive one common share.

Documents

1 file

Issuer

NOVELION THERAPEUTICS INC.

CIK 0000827809

Entity typeother

Related Parties

1
  • filerCIK 0001653133

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:01 PM ET
Size
5.5 KB